Evidence map›Paper›PMID 35833038›Full record

ArticleSouth Asian journal of cancer2022

Nivolumab in Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck: A Tertiary Cancer Center Experience.

Ananya Pareek, Apurva A Patel, Mukesh Kumar, Philip G Kuttikat, Harshavardhan Annadanam, Shantanu Pendse, Naseer Mohammed, Harsha P Panchal

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in South Asian journal of cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ananya PareekDepartment of Medical Oncology, The Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India.
Apurva A PatelDepartment of Medical Oncology, The Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India.
Mukesh KumarDepartment of Medical Oncology, The Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India.
Philip G KuttikatDepartment of Medical Oncology, The Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India.
Harshavardhan AnnadanamDepartment of Medical Oncology, The Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India.
Shantanu PendseDepartment of Medical Oncology, The Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India.
Naseer MohammedDepartment of Medical Oncology, The Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India.
Harsha P PanchalDepartment of Medical Oncology, The Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India.
Gujarat Cancer & Research Institute · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Apurva A. PatelAnanya Pareek

Indexed as

efficacymetastaticnivolumabrecurrenttoxicity

Identifiers

PMID35833038
PMCPMC9273311
OpenAlexW4206143171

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.